| TONIX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US8902608392 / A40VM0 |
| TPM0 (Frankfurt) / TNXP (NASDAQ) |
| FRA:TPM0, ETR:TPM0, TPM0:GR, NASDAQ:TNXP |
| - |
| https://www.tonixpharma.c.. |
|
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders, immunology and immuno-oncology, infectious diseases, and rare diseases. Tonix Pharmaceuticals..
>Volltext.. |
| 79.15 Mio. EUR |
| -74.24 Mio. EUR |
| 25.98 Mio. EUR |
| -145.78 Mio. EUR |
| -142.53 Mio. EUR |
| -11.55 EUR |
| 1.14 Mio. EUR |
| 157.32 Mio. EUR |
| -138.53 Mio. EUR |
| 5.72 |
| 205.34% |
| -102.27% |
| - |
| - |
| - |
| - |
| TONIX |
| 26.10.26 |
|